Mediclin AG Stock
Your prediction
Mediclin AG Stock
There is an upward development for Mediclin AG compared to yesterday, with an increase of €0.080 (2.840%).
Criterium "Expected Cash Flow" is seen as the biggest plus for Mediclin AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Mediclin AG in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mediclin AG vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Mediclin AG | 2.840% | 0.714% | 12.800% | -7.237% | 6.015% | -35.909% | -47.290% |
Vita 34 AG | -1.210% | 9.009% | 7.080% | -30.460% | -7.634% | -70.398% | -65.674% |
M1 Kliniken AG | 0.380% | -3.971% | 6.400% | 67.929% | 19.820% | 14.655% | - |
Capital Senior Living Corp. | 3.420% | 11.852% | 2.027% | 340.876% | 249.133% | -12.717% | -46.340% |
News
EQS-News: MEDICLIN buys Reha-Klinik am Sendesaal
EQS-News: MEDICLIN buys Reha-Klinik am Sendesaal
EQS-News: MEDICLIN Herzzentrum Coswig: Transfer of operations on 1 April
EQS-News: MEDICLIN Herzzentrum Coswig: Transfer of operations on 1 April
EQS-News: MEDICLIN achieves consolidated Group sales of EUR 730.1 million in 2023 - outlook for 2024 is positive
EQS-News: MEDICLIN achieves consolidated Group sales of EUR 730.1 million in 2023 - outlook for 2024 is positive